Table 4.
Prognostic outcomes | ROC-AUC value |
---|---|
Primary outcomes Mortality Presence of metastases Grade of neuroblastic differentiation Secondary outcomes Presence of IDRF MKI MYCN status |
0.76 (0.046) 0.79 (0.055) 0.77 (0.068) 0.71 (0.057) 0.63 (0.024) 0.74 (0.037) |